Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Chardan Capital analyst Daniil Gataulin reiterates Oculis Holding (NASDAQ:OCS) with a Buy and maintains $30 price target.
B of A Securities analyst Jason Gerberry maintains Oculis Holding (NASDAQ:OCS) with a Buy and lowers the price target from $...
HC Wainwright & Co. analyst Yi Chen maintains Oculis Holding (NASDAQ:OCS) with a Buy and raises the price target from $2...
Baird analyst Colleen Kusy maintains Oculis Holding (NASDAQ:OCS) with a Outperform and raises the price target from $35 to $37.
Improvements in multiple sign efficacy endpoints were observed in full population and with predictive and more pronounced eff...
HC Wainwright & Co. analyst Yi Chen reiterates Oculis Holding (NASDAQ:OCS) with a Buy and maintains $28 price target.
HC Wainwright & Co. analyst Yi Chen reiterates Oculis Holding (NASDAQ:OCS) with a Buy and maintains $28 price target.
Oculis Holding (NASDAQ:OCS) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.4...
